Literature DB >> 19741506

The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats.

Eugene Hamlyn1, Linda Brand, Mohammed Shahid, Brian H Harvey.   

Abstract

Ampakines have shown beneficial effects on cognition in selected animal models of learning. However, their ability to modify long-term spatial memory tasks has not been studied yet. This would lend credence to their possible value in treating disorders of cognition. We evaluated the actions of subchronic Org 26576 administration on spatial reference memory performance in the 5-day Morris water maze task in male Sprague-Dawley rats, at doses of 1, 3 and 10 mg/kg twice daily through intraperitoneal injection over 12 days. Org 26576 exerted a dose and time-dependent effect on spatial learning, with dosages of 3 and 10 mg/kg significantly enhancing acquisition on day 1. Globally, escape latency decreased significantly as the training days progressed in the saline and Org 26576-treated groups, indicating that significant and equal learning had taken place over the learning period. However, at the end of the learning period, all doses of Org 26576 significantly improved spatial memory storage/retrieval without confounding effects in the cued version of the task. Org 26576 offers early phase spatial memory benefits in rats, but particularly enhances search accuracy during reference memory retrieval. These results support its possible utility in treating disorders characterized by deficits in cognitive performance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741506     DOI: 10.1097/FBP.0b013e328331ba1b

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  8 in total

1.  Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.

Authors:  Kent Jardemark; Monica M Marcus; Anna Malmerfelt; Mohammed Shahid; Torgny H Svensson
Journal:  Psychopharmacology (Berl)       Date:  2011-11-09       Impact factor: 4.530

2.  AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.

Authors:  J L Silverman; C F Oliver; M N Karras; P T Gastrell; J N Crawley
Journal:  Neuropharmacology       Date:  2012-07-16       Impact factor: 5.250

3.  Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576.

Authors:  Roberta Bursi; Gul Erdemli; Robert Campbell; Matthew M Hutmacher; Thomas Kerbusch; David Spanswick; Ross Jeggo; Kari R Nations; Peter Dogterom; Jacques Schipper; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2011-06-07       Impact factor: 4.530

4.  Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome.

Authors:  Michel Baudry; Eniko Kramar; Xiaobo Xu; Homera Zadran; Stephanie Moreno; Gary Lynch; Christine Gall; Xiaoning Bi
Journal:  Neurobiol Dis       Date:  2012-04-16       Impact factor: 5.996

5.  Growth hormone and insulin-like growth factor-I alter hippocampal excitatory synaptic transmission in young and old rats.

Authors:  Doris P Molina; Olusegun J Ariwodola; Jeff L Weiner; Judy K Brunso-Bechtold; Michelle M Adams
Journal:  Age (Dordr)       Date:  2012-08-01

Review 6.  Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  CNS Spectr       Date:  2013-08-01       Impact factor: 3.790

7.  Aniracetam does not improve working memory in neurologically healthy pigeons.

Authors:  Hannah Phillips; Arlene McDowell; Birgitte S Mielby; Ian G Tucker; Michael Colombo
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

8.  Mechanism based approaches for rescuing and enhancing cognition.

Authors:  Gary Lynch; Christine M Gall
Journal:  Front Neurosci       Date:  2013-08-15       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.